Friday, September 4, 2026

Bradesco Stock Plummets 20% In 5 Sessions: Is It Time To Sell?

ViaNews Editorial Team

February 13, 2024

Bradesco Stock Plummets 20% In 5 Sessions: Is It Time To Sell?

(VIANEWS) - Banco Bradesco (NYSE: BBD) shares declined sharply on Tuesday, falling 20% in five sessions from EUR3.35 at the close of trading on March 7 to EUR2.68 by 13:11 EST at 13:11. This came after being on an upward trend the day before and following five consecutive sessions of gains by Dow Jones Industrial Average (DJIA). Banco Bradesco closed at EUR2.75, 25.27% lower than its 52-week high of EUR3.68

About Banco Bradesco

Banco Bradesco S.A. is a top Brazilian banking and financial services provider offering an expansive selection of products and services to individuals, corporates and businesses both domestically and abroad. Bank and Insurance products offered by this company range from current and savings accounts, credit products, debit and business cards, financial security services and consortium products, all the way to investment products - among others. Banco Bradesco S.A. provides insurance products such as auto, personal accident, dental, travel and life. Established in 1943 and based out of Osasco in Brazil, this renowned financial company stands out with their dedication to customer service excellence and innovation in financial products.

Yearly Analysis

As an AI language model, I don't have access to real-time stock market data and therefore am unable to give you accurate updates regarding current stock prices or the most recent changes. Based on available information, Banco Bradesco stock currently trades below its 52-week high of EUR3.68 but above its 52-week low of EUR2.34. Concerning Banco Bradesco's anticipated sales growth, if accurate information indicates investors are confident about its future development in coming years. A 21.3% sales increase this year and 10% next year could drive revenue higher and lead to greater profits; however, other factors such as competition, economic conditions, and regulatory changes that might compromise its financial performance should be taken into consideration as well. Before making investment decisions, investors should conduct in-depth research and analysis of any prospective company, taking into account factors like financial health, growth prospects, industry trends and any other pertinent considerations.

Technical Analysis

Banco Bradesco, a major Brazilian banking institution, has seen its stock value decline significantly over recent months. Their current value sits well below their 50-day moving average of EUR3.29 and 200-day moving average of EUR3.17; these results demonstrate an overall downward trend in their stock value over this timeframe. Additionally to its declining value, trading volumes for the stock have significantly declined as well. Today's reported volume is 62.970300 which represents a decrease of 70.24% below its average volume of 164077070 which shows investors lack of trust in it and decreased demand. Banco Bradesco stock has recently seen an increase in volatility, with week, month, and quarter intraday variation averages being negative 11.02%, negative 1.07% and positive 1.84%, respectively. Their highest amplitude average volatility over this timeframe being 11.02% for week 1, month 2 and quarter 3 respectively - something investors might find cause for alarm. Banco Bradesco stock appears to be overbought, as determined by the stochastic oscillator (a handy indicator of overbought/oversold conditions), according to this indicator. As such, its stock may soon experience a correction. Banco Bradesco appears to be in an unfavorable situation at this time, with its value and trading volume decreasing and increased volatility increasing. Investors should exercise extreme caution before making any definitive investment decisions regarding this stock.

Quarter Analysis

Banco Bradesco currently shows sales growth of 0.1% for this quarter, which is projected to decrease to negative 36.8% for next quarter. Nonetheless, year-on-year revenue growth was an impressive 30.1% in its past twelve month's performance with total revenues reaching 68.35B.

Equity Analysis

This text presents a financial analysis of Banco Bradesco, a Brazilian bank. It includes details about its dividend yield, earnings per share (EPS), price-to-earnings ratio (PE) ratio, and return on equity (ROE). The next dividend payment is scheduled to take place on March 4, 2024 with an expected forward annual dividend rate of 0.12 and yield estimated at 4.4%. Trailing twelve month EPS averaged EUR0.26, putting their PE ratio at 10.31 meaning each shareholder purchased is investing EUR10.31 for every euro earned annually whereas their ROE for twelve trailing months totaled 8.87% which signifies profitability relative to shareholder equity held.

More news about Banco Bradesco (BBD).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com